Covering Analysts

We are a clinical-stage biopharmaceutical company leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving cell and gene therapies for patients with high unmet medical need.

Company Analyst
BofA Securities
Geoff Meacham
Justin Zelin
Piper Sandler
Ted Tenthoff
William Blair
Raju Prashad

Poseida Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Poseida Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Poseida Therapeutics, Inc. or its management. Poseida Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.